May 17, 2023 / 07:35PM GMT
Conor Noel McNamara - RBC Capital Markets, Research Division - Analyst
Welcome to the RBC Capital Markets 2023 Global Healthcare Conference. My name is Conor McNamara. I'm the Life Science Tools and Diagnostics analyst at RBC. It's my pleasure to welcome Bio-Rad. With us are Andy Last, EVP and Chief Commercial Officer; and Ilan Daskal. Did I get that right? Okay -- Chief Operating Officer, I'm sorry. And Ilan Daskal, EVP and Chief Financial Officer. Gentlemen, thanks for joining us. Really appreciate it.
Ilan Daskal - Bio-Rad Laboratories, Inc. - Executive VP & CFO
Thanks for having us.
Conor Noel McNamara - RBC Capital Markets, Research Division - Analyst
Yes. Just let's quickly -- I don't want to dive too much on this, but give us your highlights from the quarter you just released. What are some of the things that you talked about and what are the takeaways as you've thought about it since you released the quarter, just review that really quick.
Andrew J. Last - Bio-Rad Laboratories,
Bio Rad Laboratories Inc at RBC Capital Markets Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot